Hofer & Associates’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-660
Closed -$257K – 100
2026
Q2
$257K Hold
660
– – 0.12% 59
2026
Q1
$312K Hold
660
– – 0.17% 47
2025
Q4
$308K Buy
+660
New +$306K 0.16% 47

Other funds holding HCA

Hofer & Associates's HCA Position: Q3 2026 in Review

Hofer & Associates sold out of HCA Healthcare (HCA) in Q3 2026, closing a stake of 660 shares — an estimated $257K sold.

Hofer & Associates first reported a position in HCA in Q4 2025 and held it in 3 quarters. The position peaked at $312K in Q1 2026. 713 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Hofer & Associates reported no remaining HCA Healthcare position as of Q3 2026 after selling out during the quarter.
  • Hofer & Associates sold 660 HCA Healthcare shares in Q3 2026, an estimated $257K.
  • Hofer & Associates first reported a position in HCA Healthcare in Q4 2025 and held it in 3 quarters.
  • Hofer & Associates's HCA Healthcare position peaked at $312K in Q1 2026.
  • 713 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Hofer & Associates's 13F filing for Q3 2026, filed 13 Oct 2026.